Effect of anti-rheumatic drugs on the clinical outcome of
autoimmune rheumatic diseases patients infected with COVID-19: A
systemic review and meta-analysis
Qin-Yi Su1,2,3#, Sheng-Xiao
Zhang1,2,3#, Jing Luo1,2,3, Ting
Cheng1,2,3, He-Yi Zhang2,3, Yan
Zhang2,3, Bing-Ru Zhao2,3, Chong
Gao4, Cai-Hong Wang1,2,3*
1 Department of Rheumatology, The Second Hospital of Shanxi
Medical University, Taiyuan, Shanxi, China. 2 Shanxi Provincial
Key Laboratory of Rheumatism Immune Microecology, Taiyuan, Shanxi,
China. 3 Key Laboratory of Cellular Physiology at Shanxi
Medical University, Ministry of Education, Taiyuan, China. 4Brigham and Women’s Hospital, Harvard Medical School, Department of
Pathology, Boston, United States of America
#Qin-Yi Su and Sheng-Xiao Zhang contributed to the work equally and
should be regarded as co-first authors.
* Cai-Hong Wang is corresponding authors.
*Cai-Hong Wang: Phone number: +8613603515399; E-mail address:
snwch@sina.com;Present address: 382, Wuyi Road, Taiyuan, Shanxi